Curis Inc. (CRIS) Soars 9.55% on April 01
Curis Inc. (CRIS) had a good day on the market for Monday April 01 as shares jumped 9.55% to close at $2.18. About 1.54 million shares traded hands on 4,574 trades for the day, compared with an average daily…
From the Equity Insider archive. This article dates from Apr 2, 2019 and is preserved as first published.
Curis Inc. (CRIS) had a good day on the market for Monday April 01 as shares jumped 9.55% to close at $2.18. About 1.54 million shares traded hands on 4,574 trades for the day, compared with an average daily volume of n/a shares out of a total float of 33.15 million. After opening the trading day at $1.95, shares of Curis Inc. stayed within a range of $2.22 to $1.95.
With today’s gains, Curis Inc. now has a market cap of $72.27 million. Shares of Curis Inc. have been trading within a range of $3.50 and $0.60 over the last year, and it had a 50-day SMA of $n/a and a 200-day SMA of $n/a.
60 over the last year, and it had a 50-day SMA of $n/a and a 200-day SMA of $n/a.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include CUDC-907, CA-170, CA-4948, CA-327, and Erivedge.
Curis Inc. is based out of Lexington, MA and has some 55 employees. Its CEO is James E. Dentzer.
